Krilogy Financial LLC bought a new position in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) in the first quarter, HoldingsChannel reports. The firm bought 7,093 shares of the financial services provider’s stock, valued at approximately $1,295,000.
A number of other institutional investors have also recently modified their holdings of the business. Solstein Capital LLC acquired a new stake in shares of Marsh & McLennan Companies in the fourth quarter valued at about $25,000. SHP Wealth Management purchased a new position in Marsh & McLennan Companies in the fourth quarter valued at about $26,000. KERR FINANCIAL PLANNING Corp purchased a new position in Marsh & McLennan Companies in the fourth quarter valued at about $27,000. Golden State Wealth Management LLC purchased a new stake in shares of Marsh & McLennan Companies during the 4th quarter worth approximately $27,000. Finally, Atlas Capital Advisors Inc. purchased a new stake in shares of Marsh & McLennan Companies during the 4th quarter worth approximately $28,000. 87.99% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
MRSH has been the subject of several research analyst reports. Weiss Ratings downgraded Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, May 11th. UBS Group dropped their price target on Marsh & McLennan Companies from $230.00 to $203.00 and set a “buy” rating for the company in a research report on Tuesday, June 9th. Barclays cut their price target on Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating for the company in a research note on Wednesday, April 8th. Citigroup raised shares of Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 price objective on the stock in a research note on Wednesday, May 6th. Finally, Mizuho cut their target price on shares of Marsh & McLennan Companies from $199.00 to $193.00 and set a “neutral” rating for the company in a research report on Monday, April 13th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $200.19.
Marsh & McLennan Companies Price Performance
Marsh & McLennan Companies stock opened at $162.22 on Friday. Marsh & McLennan Companies, Inc. has a fifty-two week low of $156.60 and a fifty-two week high of $219.71. The firm has a market cap of $78.37 billion, a price-to-earnings ratio of 20.28, a P/E/G ratio of 2.42 and a beta of 0.62. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 1.28.
Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last announced its earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.21 by $0.08. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The firm had revenue of $7.30 billion for the quarter. The business’s quarterly revenue was up 7.6% compared to the same quarter last year. Research analysts predict that Marsh & McLennan Companies, Inc. will post 10.38 earnings per share for the current year.
Insider Activity at Marsh & McLennan Companies
In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 16,656 shares of the company’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the completion of the sale, the chief executive officer directly owned 116,811 shares in the company, valued at $18,889,506.81. This represents a 12.48% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.38% of the stock is currently owned by insiders.
About Marsh & McLennan Companies
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Recommended Stories
- Five stocks we like better than Marsh & McLennan Companies
- MDA Space Targets US Defense Market With $620M Acquisition
- Carnival’s Second Quarter: Is the Stock Still Complicated?
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
- Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
